Navigation Links
Blood Test May Catch Deadly Fungal Infection Quickly
Date:4/24/2013

By Amy Norton
HealthDay Reporter

WEDNESDAY, April 24 (HealthDay News) -- An experimental test could help doctors catch a deadly type of fungal infection in the blood within a few hours, rather than the few days it currently takes, a new study suggests.

The test, which is not yet on the market, looks for Candida infection in the blood. The fungus is best known for causing common vaginal yeast infections, but when it gets into the bloodstream it can cause serious infections of organs and tissue throughout the body.

Candida blood infections -- known as candidemia -- are very rare in healthy people, but they are the fourth most common type of blood infection among U.S. hospital patients, according to the U.S. Centers for Disease Control and Prevention.

The infection is typically transmitted through contaminated catheters, and seen in seriously ill patients -- such as those in the intensive care unit, or with weakened immune systems.

The symptoms of candidemia are vague, and include fever and chills, so doctors use blood cultures to diagnose it. That means putting a blood sample in a special broth that feeds the yeast organism until it grows enough to be detected.

But Candida "is a slow grower," and it takes a few days to get blood culture results back, said Thomas Lowery of T2 Biosystems, the Lexington, Mass.-based company developing the new test.

By that time, it may be too late for the patient. About 40 percent of people with Candida blood infections die, and delayed diagnosis bears part of the blame, Lowery and his colleagues write in the April 24 issue of the journal Science Translational Medicine.

Getting a precise diagnosis is vital, Lowery said, both to confirm that it's Candida, and to pinpoint which type it is. "You need to know the specific Candida so you can use the right antifungal drug," he said.

In the new study, Lowery's team found that the test they've developed can reliably detect the five most common species of Candida within about three hours.

The researchers used blood samples from healthy people and "spiked" them with Candida yeast. They then analyzed the samples with the new test and with standard blood cultures. The two tests were in agreement on "positives" 98 percent of the time.

An expert not involved in the research said the test's sensitivity is "very, very good."

"This is preliminary, but the technology looks extremely promising," said Christine Ginocchio, chief of infectious disease diagnostics at North Shore-LIJ Health System in Lake Success, N.Y.

What's particularly "exciting" is that the technology could potentially be used to test for other pathogens that cause serious bloodstream infections, according to Ginocchio, who is also a member of the Infectious Diseases Society of America's Diagnostics Task Force.

Ideally, Ginocchio explained, when doctors suspect a patient has a bloodstream infection, they would be able to take a blood sample, directly test it, then have a result in a few hours. The problem right now is that a blood sample would normally not contain enough of the culprit bug -- be it a fungus or bacterium -- to detect.

Plus, Ginocchio noted, the blood contains a lot of other genetic material that gets in the way of spotting that bit of foreign-invader DNA. That's why blood cultures are done.

The new test, which is based on so-called magnetic resonance technology, essentially removes the "noise" coming from other material in the blood sample, allowing it to zero in on the pathogen.

There is still more work to be done. "Now you'd like to see this tested in a larger, multicenter trial," Ginocchio said.

The process would also need to be automated, she noted, to be feasible for smaller community hospitals. T2 Biosystems' Lowery said the researchers are working on making the method "fully automated."

Exactly what it would all cost is not known. But both Ginocchio and Lowery said that if the test gets more patients on the right drug quickly, the cost would likely be worth it.

According to Lowery's team, research suggests that with Candida infections, starting the right antifungal drug within 12 hours can cut the death rate from 40 percent to 11 percent.

More information

Learn more about Candida blood infections from the U.S. Centers for Disease Control and Prevention.

SOURCES: Thomas Lowery, Ph.D., vice president, diagnostics research and development, T2 Biosystems, Lexington, Mass; Christine Ginocchio, Ph.D., chief, infectious disease diagnostics, North Shore-LIJ Health Systems Laboratories, Lake Success, N.Y.; April 24, 2013, Science Translational Medicine, online


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Off-the-Shelf Artificial Blood Vessels Show Promise
2. Exercise, Alternative Therapies May Help Lower Blood Pressure
3. Metastasis stem cells in the blood of breast cancer patients discovered
4. Tekturna Infographic Released by d’Oliveira & Associates Imparts Potential Side Effects of Blood Pressure Drug
5. Blood pressure out of control at safety-net clinics
6. Rockford Ravens Rugby Football Club to Host Blood Drive with Rock River Valley Blood Center
7. Increased risk of cardiovascular disease for pregnant women with high blood pressure
8. 2013 NuvaRing Blood-Clotting Allegations Inquiries Eligible for Review by Resource4thePeople Attorneys
9. Blood Drive at Crimson Pointe Assisted Living Facility with Rock River Valley Blood Center
10. Could Coffee Bean Extract Help Control Blood Sugar?
11. Blood tests can provide fuller picture of mutations in cancer than traditional biopsies do
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Test May Catch Deadly Fungal Infection Quickly
(Date:3/24/2017)... ... ... who like to educate themselves on current issues and who enjoy gaining knowledge on ... to appreciate and love the "Informed" series, hosted by Rob Lowe. A new ... the world. , Running for charity has become a multi-million dollar enterprise ...
(Date:3/24/2017)... ... 24, 2017 , ... Empower Brokerage, located in Southlake, Texas, ... programs. , In February, 2017, Empower Brokerage introduced their new “Performance Partners” program ... to teach how to maximize their sales efforts, as well as how to ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Finding Christ Through Social ... devotional journal chronicling the writer’s path toward true communion with God. “Finding Christ ... #TruthwithGrace” is the creation of published author Lea Michelle Johnson, a follower of ...
(Date:3/24/2017)... ... ... and Harvest A Cultivation of Christian Love” is the creation of published author, David ... wife, Anna Marie. He and his wife are the proud parents of four grown ... “Shadow and Substance.” , “Love, the agape kind, is seen as more than an ...
(Date:3/24/2017)... ... , ... “The Adventures of Joey, The Dog Who Barks at Puddles”: a ... to the fullest, as God intended. “The Adventures of Joey, The Dog Who Barks ... pursuing her passion for writing, especially about truth and human behavior. , Published by ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , March 24, 2017 New England ... recipient of an award including funding and in-kind service ... draw technology.  "Making blood draws less ... making their whole hospital experience better.  We,re looking forward ... technology can help improve care for the kids we ...
(Date:3/24/2017)... YORK , March 24, 2017   ... leading organization within medical affairs in the pharmaceutical ... as the chair of a newly formed scientific ... board members to form the first ever medical ... For more information about the ACMA, please ...
(Date:3/24/2017)... Research and Markets has announced the addition ... - 2035" report to their offering. ... The Deep Learning: Drug Discovery and Diagnostics ... the growing market of deep learning solutions within the healthcare domain. ... emerged as a novel solution to generate relevant insights from medical ...
Breaking Medicine Technology: